What the site is for
Retatrutide is an investigational drug. Interest in it has run far ahead of any lawful supply, and a market of research-chemical vendors, grey-market sellers and affiliate ranking pages has grown into the gap. Most of what a searcher finds is written by someone who is paid when they click.
This site is written to be the page that shows, before anyone orders anything, what each vendor can actually prove: a registered company, a lot on the vial, a named laboratory, a price, a shipping window, a payment method. The pick, OXpeptides (https://oxpeptides.com), comes out of that grid and is disclosed on every page where it appears.
How pages are researched
Sources are limited to peer-reviewed publications with a DOI that resolves on CrossRef, trial records with an NCT number that resolves on ClinicalTrials.gov, and primary regulatory or manufacturer pages. Each was checked against those registries on the publication date.
Vendor facts are what a vendor's own page showed on the day of the check, recorded with the date. Where a page did not show something, the table says so; nothing is inferred from reviews or forums. Search demand was measured before writing, so each page answers a question people actually ask, in the words they use.
What the site does not do
- It does not sell retatrutide or any other product, and it does not process payments.
- It does not publish vendor reviews, testimonials or star ratings.
- It does not give dosing, medical or treatment advice; trial doses are reported as trial data with their source.
- It does not run analytics, advertising, cookies or trackers of any kind.
- It does not accept paid placement; the pick is an editorial choice, disclosed everywhere it appears.
Corrections and contact
If a figure, a citation, a vendor fact or a legal statement on this site is wrong or out of date, write to editor@where-to-buy-retatrutide.com with the page address and the source that contradicts it. Corrections are made in the page, the updated date changes, and material corrections are noted at the end of the page. Requests to add, remove or promote a vendor are not acted on.
The editorial rules in full are on the editorial policy page. The verdict starts at where to buy retatrutide in 2026.
